Answers are grounded in this paper and cite their sources.
Introduction: Lymphoplasmacytic lymphoma (LPL) is a rare indolent mature B-cell lymphoma and 90% to 95% LPL secrete monoclonal immunoglobulin M (IgM) protein. Only a small number of LPL secrete non-IgM monoclonal protein. Patient concerns: We report the case of an 86-year-old-male who was admitted to our hospital with a history of fatigue for 7 years and poor appetite for 3 months. Diagnoses: According to the M component IgA-κ and IgM-κ, plasmacytic differentiation lymphocytes in bone marrow biopsy and MYD88 mutation, the patient was diagnosed as LPL with paraprotein IgA and IgM. Interventions: Given the old age and expensive cost, the patient gave up chemotherapy and target therapy, and received only supportive treatment of intermittent transfusion. Outcomes: The patient has survived for more than 1 year with the supportive treatment. Conclusion: LPL with paraprotein IgA and IgM is a very rare indolent disease. Further studies with more patients are required to investigate the clinical outcomes.
No takes yet. Share an insight, caveat, or question.
Zheng et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: